German drugmaker Boehringer Ingelheim said on Thursday it is facing more than 2,000 lawsuits in the United States over claims its blockbuster drug Pradaxa, the first in a new class of stroke prevention pills, caused severe and fatal bleeding.
Drugmaker facing more than 2,000 U.S. lawsuits over blood thinner
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.